Uroxatral is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is Alfuzosin Hydrochloride.
Product ID | 59212-200_2f119319-ba14-4824-a2dd-5e01f737674a |
NDC | 59212-200 |
Product Type | Human Prescription Drug |
Proprietary Name | Uroxatral |
Generic Name | Alfuzosin Hcl |
Dosage Form | Tablet, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2013-06-03 |
Marketing Category | NDA / NDA |
Application Number | NDA021287 |
Labeler Name | Concordia Pharmaceuticals Inc. |
Substance Name | ALFUZOSIN HYDROCHLORIDE |
Active Ingredient Strength | 10 mg/1 |
Pharm Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2013-06-03 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021287 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-06-03 |
Marketing End Date | 2019-01-31 |
Marketing Category | NDA |
Application Number | NDA021287 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-06-03 |
Marketing Category | NDA |
Application Number | NDA021287 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-01-18 |
Ingredient | Strength |
---|---|
ALFUZOSIN HYDROCHLORIDE | 10 mg/1 |
SPL SET ID: | 9fc7f119-f36b-44cf-945d-940160f3afe3 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
UROXATRAL 76233890 2679884 Live/Registered |
Concordia Pharmaceuticals Inc. 2001-03-28 |